Simon C. Pedder
Simon C. Pedder is a businessperson who founded Chelsea Therapeutics International Ltd. and who has been at the head of 6 different companies. Currently, he is Executive Chairman & President at Cerecor, Inc. He is also on the board of Eboo Pharmaceuticals, Inc., Ballantyne Therapeutics, Inc. and Atlantic Research Group, Inc. and Chief Business & Strategy Officer-Proprietary at Athenex, Inc.
In his past career he occupied the position of President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President, Chief Executive Officer & Director at Chelsea Therapeutics International Ltd., President & Chief Executive Officer of Chelsea Therapeutics, Inc., President & Chief Executive Officer of Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc., Vice President-Drug Development at Shearwater Corp. and Member of the University of Saskatchewan College of Medicine.
He received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.
Transactions
| 04/09/2020 | 20,901 | Derivative/Non-derivative trans. at $2.57 per share. | 53,716 |
| 08/27/2019 | 6,734 | Acquisition at $2.98 per share. | 20,067 |
| 05/24/2019 | 250,000 | Award at $0 per share. | 0 |
| 05/14/2019 | 6,000 | Acquisition at $5.06 per share. | 30,360 |
